Newsfeeds - Spark Newswire

4 minute read

Nasdaq Futures Climb Solidly After Past Week’s Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows

Today, 4:42 PM

After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.

AMGN

1 minute read

Sanofi Has Agreed To Acquire Provention Bio For $25.00/Share In Cash, Representing An Equity Value Of Approximately $2.9B

By Benzinga Newsdesk

Today, 4:42 PM

https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367

PRVB

1 minute read

HC Wainwright & Co. Maintains Buy on Provention Bio, Lowers Price Target to $16

By Benzinga Newsdesk

Today, 4:42 PM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Provention Bio (NASDAQ:PRVB) with a Buy and lowers the price target from $18 to $16.

PRVB

1 minute read

UnitedHealth Is Now Providing Insurance Coverage For Prevention Bio’s Tzield (For The Delay Of Diabetes) Effective February 1

By Happy Mohamed

Today, 4:42 PM

https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/tzield.pdf

PRVB

1 minute read

Watching Provention Bio; Shares Move Lower As Co Showcases Webinar Titled ‘Tzield: Learn More About A Newly Approved Therapy’

By Benzinga Newsdesk

Today, 4:42 PM

https://members.amcp.org/AMCP2019/Events/Event_Display.aspx?EventKey=GTW_230118&WebsiteKey=2bfc55cc-0861-4d8b-91d1-9a8c0f748666

PRVB

1 minute read

‘Provention Bio’s Recently Approved Drug Tzield (Teplizumab) For The Delay Of Clinical Type 1 Diabetes Has Been Added To The Department Of Veterans Affairs National Acquisition Center Drug Catalog’

By Benzinga Newsdesk

Today, 4:42 PM

https://www.vendorportal.ecms.va.gov/NAC/Pharma/Details?NDC=73650031601&CNT=36F79723D017E

PRVB

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 4:42 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ALGN

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 4:42 PM

4 minute read

Mirati Plays Catch-Up With Amgen, Gilead’s 2nd Try With AIDS Drug, Cytokinetics’ Adcom Test And More: Key Nov FDA Decisions For Biotech Investors

By Shanthi Rexaline

Today, 4:42 PM

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.

AMGN

6 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 4:42 PM

On Friday, 68 companies reached new 52-week highs.

ABC